Ledger.Open graph →
SEC Form D · Amendment · filed May 22, 2018

FGH Biotech, Inc

Offering
$4.0M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Lufti J. Abu-Elheiga · Houston, TXExecSalih J. Wakil · Houston, TXExec · DirectorAdam J. Kuspa · Houston, TXDirectorJoe Wakil · Houston, TXExec · DirectorBrent Rassmussen · Hinsdale, ILExecKevin Knaul · Hinsdale, ILDirectorMichael S. Dell · Round Rock, TXExec · DirectorWilliam D. Green · Round Rock, TXExec · DirectorSteven H. Price · Round Rock, TXDirectorMarius I. Haas · Round Rock, TXExecThomas W. Sweet · Round Rock, TXExec · DirectorKaren H. Quintos · Round Rock, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗